Suppr超能文献

成年斯里兰卡炎症性肠病患者的骨质疏松症

Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.

作者信息

de Silva Arjuna Priyadarsin, Karunanayake Aranjan Lionel, Dissanayaka Thalahitiya Gamaralalage Iruka, Dassanayake Anuradha Supun, Duminda Hewa Kattadi Kankanamgae Tilak, Pathmeswaran Arunasalam, Wickramasinghe Ananda Rajitha, de Silva Hithanadura Janaka

机构信息

Department of Medicine, Faculty of Medicine, University of Kelaniya, PO Box 6, Thalagolla Road, Ragama GQ11010, Sri Lanka.

出版信息

World J Gastroenterol. 2009 Jul 28;15(28):3528-31. doi: 10.3748/wjg.15.3528.

Abstract

AIM

To determine if inflammatory bowel disease (IBD) is a risk factor for osteoporosis in adult Sri Lankans.

METHODS

We identified eligible subjects from among consecutive patients diagnosed with IBD who attended our outpatient clinic. We included only patients aged between 20 and 70 years. Patients who were pregnant, had significant comorbidity, or were on calcium supplements or treatment for osteoporosis within the past 6 mo, were excluded. Healthy, age- and sex-matched controls were also recruited, in a control to patient ratio of 3:1. Both groups were screened for osteoporosis using peripheral dual energy X-ray absorptiometry scanning.

RESULTS

The study population consisted of 111 IBD patients (male:female = 43:68; mean age 42.5 years) and 333 controls (male:female = 129:204; mean age 43.8 years). The occurrence of osteoporosis among IBD patients (13.5%) was significantly higher than among controls (4.5%) (P = 0.001). The frequency of osteoporosis was not significantly different between ulcerative colitis (14.45%) and Crohn's disease (10.7%). However, on multivariate analysis, only age (P = 0.001), menopause (P = 0.024) and use of systemic steroids (P < 0.001) were found to be associated independently with the occurrence of osteoporosis, while IBD, severity of disease, number of relapses, duration of illness or treatment other than systemic steroids were not.

CONCLUSION

IBD does not appear to be an independent risk factor for the occurrence of osteoporosis in this population. However, the use of systemic steroids was a risk factor.

摘要

目的

确定炎症性肠病(IBD)是否为成年斯里兰卡人骨质疏松症的危险因素。

方法

我们从连续就诊于我院门诊并被诊断为IBD的患者中确定符合条件的受试者。仅纳入年龄在20至70岁之间的患者。排除怀孕、有严重合并症或在过去6个月内服用钙补充剂或接受骨质疏松症治疗的患者。还招募了年龄和性别匹配的健康对照,对照与患者的比例为3:1。两组均采用外周双能X线吸收法扫描筛查骨质疏松症。

结果

研究人群包括111例IBD患者(男:女 = 43:68;平均年龄42.5岁)和333例对照(男:女 = 129:204;平均年龄43.8岁)。IBD患者中骨质疏松症的发生率(13.5%)显著高于对照组(4.5%)(P = 0.001)。溃疡性结肠炎(14.45%)和克罗恩病(10.7%)之间骨质疏松症的发生率无显著差异。然而,多因素分析显示,仅年龄(P = 0.001)、绝经(P = 0.024)和全身用类固醇的使用(P < 0.001)与骨质疏松症的发生独立相关,而IBD、疾病严重程度、复发次数、病程或全身用类固醇以外的治疗则无关。

结论

在该人群中,IBD似乎不是骨质疏松症发生的独立危险因素。然而,全身用类固醇的使用是一个危险因素。

相似文献

1
Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.
World J Gastroenterol. 2009 Jul 28;15(28):3528-31. doi: 10.3748/wjg.15.3528.
2
Prevalence of low bone mineral density in inflammatory bowel disease and factors associated with it.
Indian J Gastroenterol. 2020 Aug;39(4):346-353. doi: 10.1007/s12664-020-01048-5. Epub 2020 Sep 17.
3
Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
Digestion. 2006;73(1):40-6. doi: 10.1159/000092013. Epub 2006 Mar 14.
4
Bone density improves with disease remission in patients with inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1267-73. doi: 10.1097/00042737-200312000-00003.
5
Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
Osteoporos Int. 2017 Jul;28(7):2167-2176. doi: 10.1007/s00198-017-4014-3. Epub 2017 Apr 12.
6
The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease.
Bratisl Lek Listy. 2013;114(8):439-45. doi: 10.4149/bll_2013_092.
7
Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients?
J Crohns Colitis. 2013 Dec;7(11):901-7. doi: 10.1016/j.crohns.2012.12.008. Epub 2013 Jan 18.
9
Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2016 Jul;28(7):814-9. doi: 10.1097/MEG.0000000000000617.
10

引用本文的文献

1
Two-sample Mendelian randomization analysis evaluates causal associations between inflammatory bowel disease and osteoporosis.
Front Public Health. 2023 May 26;11:1151837. doi: 10.3389/fpubh.2023.1151837. eCollection 2023.
2
Bone alterations in inflammatory bowel diseases.
World J Clin Cases. 2019 Aug 6;7(15):1908-1925. doi: 10.12998/wjcc.v7.i15.1908.
3
Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain.
Therap Adv Gastroenterol. 2019 Jul 31;12:1756284819862152. doi: 10.1177/1756284819862152. eCollection 2019.
5
[The decrease in bone density in chronic inflammatory bowel disease: prevalence and risk factors].
Pan Afr Med J. 2013 Jun 25;15:70. doi: 10.11604/pamj.2013.15.70.2859. eCollection 2013.

本文引用的文献

1
Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women.
Appl Health Econ Health Policy. 2008;6(2-3):113-35. doi: 10.1007/BF03256127.
2
Race and diet interactions in the acquisition, maintenance, and loss of bone.
J Nutr. 2008 Jun;138(6):1256S-60S. doi: 10.1093/jn/138.6.1256S.
3
Emergence of inflammatory bowel disease 'beyond the West': do prosperity and improved hygiene have a role?
Trans R Soc Trop Med Hyg. 2008 Sep;102(9):857-60. doi: 10.1016/j.trstmh.2008.03.016. Epub 2008 May 2.
4
Gut, inflammation and osteoporosis: basic and clinical concepts.
Gut. 2008 May;57(5):684-94. doi: 10.1136/gut.2006.117382.
7
Basic and clinical aspects of osteoporosis in inflammatory bowel disease.
World J Gastroenterol. 2007 Dec 14;13(46):6156-65. doi: 10.3748/wjg.v13.i46.6156.
9
Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review.
Endocr Pract. 2006 Nov-Dec;12(6):622-9. doi: 10.4158/EP.12.6.622.
10
Bone density testing in clinical practice.
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):586-95. doi: 10.1590/s0004-27302006000400004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验